These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9283243)

  • 1. Human intravenous immunoglobulin therapy.
    Scott-Moncrieff JC; Reagan WJ
    Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):178-85. PubMed ID: 9283243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin.
    Spurlock NK; Prittie JE
    J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):471-83. PubMed ID: 22316195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
    Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
    J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Human Intravenous Immunoglobulin in Veterinary Clinical Practice.
    Spurlock N; Prittie J
    Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1371-1383. PubMed ID: 32896436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human intravenous immunoglobulin use for hematological immune-mediated disease in dogs.
    Kane BK; Greer RM
    J Am Vet Med Assoc; 2023 Jul; 261(7):1004-1010. PubMed ID: 37072115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia.
    Whelan MF; O'Toole TE; Chan DL; Rozanski EA; DeLaforcade AM; Crawford SL; Cotter SM
    J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):158-64. PubMed ID: 19691566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs.
    Bianco D; Armstrong PJ; Washabau RJ
    J Vet Intern Med; 2007; 21(4):694-9. PubMed ID: 17708388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
    Oggier D; Tomsa K; Mevissen M; Glaus T
    Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
    Gerber B; Steger A; Hässig M; Glaus TM
    Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs.
    Bianco D; Armstrong PJ; Washabau RJ
    J Vet Intern Med; 2009; 23(5):1071-8. PubMed ID: 19674280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.
    Grobman M; Outi H; Rindt H; Reinero C
    J Vet Intern Med; 2017 Sep; 31(5):1430-1440. PubMed ID: 28804921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia.
    Stikeman E; Bianco D
    J Small Anim Pract; 2024 May; 65(5):338-345. PubMed ID: 38239177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs.
    Balog K; Huang AA; Sum SO; Moore GE; Thompson C; Scott-Moncrieff JC
    J Vet Intern Med; 2013; 27(3):536-41. PubMed ID: 23527952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia.
    Bestwick JP; Sharman M; Whitley NT; Kisielewicz C; Skelly BJ; Tappin S; Kellett-Gregory L; Seth M
    J Vet Intern Med; 2022 Jan; 36(1):78-85. PubMed ID: 34779044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human intravenous immunoglobulin (hIVIG) inhibits anti-CD32 antibody binding to canine DH82 cells and canine monocytes in vitro.
    Sibley TA; Miller MM; Fogle JE
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):229-34. PubMed ID: 23276750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-thymocyte serum as part of an immunosuppressive regimen in treating haematological immune-mediated diseases in dogs.
    Cuq B; Blois SL; Mathews KA
    J Small Anim Pract; 2017 Jun; 58(6):348-354. PubMed ID: 28369956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial monitoring of clinical, haematological and immunological parameters in canine autoimmune haemolytic anaemia.
    Day MJ
    J Small Anim Pract; 1996 Nov; 37(11):523-34. PubMed ID: 8934425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.